Inventor
Zhi-Fu Tao
Inventor
Gurnee, IL, US
Overview
Patents· 45 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds33%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations31%
A61KPreparations for medical, dental or toiletry purposes27%
Y02ATechnologies for adaptation to climate change5%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
C07CAcyclic or carbocyclic compounds1%
PatentTitleYear
10,676,485Macrocyclic MCL-1 inhibitors and methods of use202010,081,628Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases20189,877,958'Apoptosis-induced agents for the treatment of cancer and immune and autoimmune diseases'20189,844,547Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases20179,796,708'Pyrrolo [2,3-B] pyridine CDK9 kinase inhibitors'20179,650,358'Pyridine CDK9 kinase inhibitors'20179,403,822'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,359,296'7-substituted indole Mcl-1 inhibitors'20169,346,813'Substituted pyrrolo[2,3-d]pyrimindines as CDK9 kinase inhibitors'20169,315,488'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20169,303,025'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,266,877'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,227,963'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20169,174,982'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,125,913'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,073,922'Pyrrolo[2,3-B]pyridine CDK9 kinase inhibitors'20159,072,748'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,073,855'BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,045,420'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20159,045,475'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,035,047'7-substituted indole Mcl-1 inhibitors'20159,034,875'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,029,404'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20159,006,247'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,969,375'CDK9 kinase inhibitors'20158,952,157'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,940,737'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20158,889,675'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20148,883,784'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20148,853,209'1-oxyalkyl-2-carboxy-7-nonsubstituted indole derivatives'20148,586,754'BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,580,794'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,563,735'Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases'20138,557,983'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,546,399'Apoptosis inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,445,679'7-substituted indole MCL-1 inhibitors'20138,426,422'Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases'20138,232,273'Heterocyclic compounds and methods of use'20128,148,384'Substituted thieno[3,2-d]pyrimidine PIM kinase inhibitors as cancer chemotherapeutics'20127,981,888'1-oxyalkyl-2-carboxyl-7-nonsubstituted indole derivatives'20117,956,185'Cyclobut-3-ene-1,2,-dione inhibitors of polo-like kinases'20117,320,986'Fused tri and tetra-cyclic pyrazole kinase inhibitors'20087,163,939'Macrocyclic kinase inhibitors'20076,713,633'Compounds capable of cleaving double-stranded DNA and method of utilization of the same'20046,566,336'Compounds alkylating specific base sequence of DNA and method for synthesizing the same'2003Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2003Based in Tokyo, JP· patent location history
2004Based in Charlottesville, VA, US· patent location history
2007–2018Based in Gurnee, IL, US· patent location history
2012–2015Patents assigned to TAO ZHI-FU (11)· patent assignee history
2012–2015Patents assigned to SOUERS ANDREW J (9)· patent assignee history
2012–2014Patents assigned to ELMORE STEVEN W (8)· patent assignee history
2012–2013Patents assigned to WANG LE (8)· patent assignee history
2013–2020Patents assigned to ABBVIE INC (37)· patent assignee history
2013Based in Gunree, IL, US· patent location history
2014–2020Based in Vernon Hills, IL, US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ABBVIE INC | 37 | 2013–2020 |
| TAO ZHI-FUself | 11 | 2012–2015 |
| SOUERS ANDREW J | 9 | 2012–2015 |
| ELMORE STEVEN W | 8 | 2012–2014 |
| WANG LE | 8 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Gurnee, Illinois, US | 34 | 2007–2018 |
| Vernon Hills, Illinois, US | 8 | 2014–2020 |
| Gunree, Illinois, US | 1 | 2013 |
| Charlottesville, Virginia, US | 1 | 2004 |
| Tokyo, JP | 1 | 2003 |